- Conditions
- Salt-sensitive Hypertension
- Interventions
- Fenoldopam
- Drug
- Lead sponsor
- Georgetown University
- Other
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 45 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2002 – 2006
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
Source: ClinicalTrials.gov public record
Updated Mar 27, 2011 · Synced May 22, 2026, 1:17 AM EDT